Exscientia

Exscientia outline robot and AI use in drug discovery workflow
Clinical Trials Arena
Wed, 10/2/24 - 11:01 am
Exscientia
robotics
drug discovery
artificial intelligence
Recursion, Exscientia, and AI drug discovery’s moment of truth
Pharmaphorum
Thu, 08/15/24 - 11:29 am
Recursion
Exscientia
drug discovery
artificial intelligence
AI biotechs Exscientia and Recursion agree to $688m merger
Pharmaphorum
Thu, 08/8/24 - 11:20 am
artificial intelligence
drug development
M&A
Exscientia
Recursion
Exscientia pays $20M for full control of CDK7 drug, plans breast cancer combo trial
Fierce Biotech
Thu, 07/18/24 - 11:10 am
Exscientia
GT Apeiron
M&A
breast cancer
GTAEXS617
Exscientia cuts a quarter of staff while preserving AI-generated pipeline
Fierce Biotech
Tue, 05/21/24 - 11:23 am
Exscientia
artificial intelligence
layoffs
Exscientia fires CEO Andrew Hopkins over 'inappropriate' relationships with 2 employees
Fierce Biotech
Tue, 02/13/24 - 11:26 am
artificial intelligence
Exscientia
Exscientia has the potential to be a star collaborator and a profitable drug developer
Motley Fool
Fri, 12/8/23 - 10:03 am
Exscientia
drug discovery
artificial intelligence
AI drug hunter Exscientia chops down 'rapidly emerging pipeline' to focus on 2 main oncology programs
Fierce Biotech
Tue, 10/3/23 - 11:58 am
Exscientia
artificial intelligence
drug development
Merck KGaA doubles up on AI partners, tapping BenevolentAI and Exscientia for drug discovery push
Fierce Biotech
Wed, 09/20/23 - 08:37 am
Merck KGaA
drug discovery
artificial intelligence
BenevolentAI
Exscientia
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Wed, 03/15/23 - 09:57 am
Exscientia
Bristol Myers Squibb
oncology
EXS73565
EXS74539
Sanofi makes AI play, putting up $100M and billions in biobucks to form broad deal with Exscientia
Fierce Biotech
Fri, 01/7/22 - 10:37 am
Sanofi
R&D
artificial intelligence
Exscientia
Trio of Biopharmas Generates Over $500 Million for AI, Oncology Innovation
BioSpace
Mon, 10/4/21 - 10:34 am
funding
artificial intelligence
oncology
TrialSpark
CBMG Holdings
Exscientia
The cash won't stop for Exscientia as it makes a $300M+ Nasdaq debut
Endpoints
Sun, 10/3/21 - 08:16 pm
Exscientia
IPOs
artificial intelligence
Five Life Sciences Companies Ramping up the Fall Flood of IPOs
BioSpace
Mon, 09/13/21 - 11:28 pm
IPOs
Exscientia
Sumitomo Dainippon Pharma
Cingluate
Tyra Biosciences
Procept BioRobotics
Gates Foundation backs COVID R&D at AI firm Exscientia
Pharmaforum
Thu, 07/8/21 - 11:01 am
Gates Foundation
Exscientia
R&D
COVID-19
artificial intelligence
UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing
Pharmaforum
Tue, 07/6/21 - 10:36 am
UK
biotech
Centessa
Achilles Therapeutics
Vaccitech
Exscientia
Oxford Nanopore
Gyroscope Therapeutics
Exscientia buys Allcyte to add patient sample testing to its AI platform
Pharmforum
Wed, 06/16/21 - 11:44 am
Exscientia
Allcyte
M&A
artificial intelligence
Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step
Endpoints
Wed, 05/19/21 - 10:33 am
Bristol Myers Squibb
Exscientia
R&D
Celgene
M&A
artificial intelligence
Exscientia starts trials of first AI-derived cancer immunotherapy
Pharmaforum
Mon, 04/12/21 - 10:31 am
Exscientia
cancer immunotherapy
artificial intelligence
After years of partnerships, AI biotech Exscientia lands first major financing round at $60M
Endpoints
Tue, 05/26/20 - 11:04 am
artificial intelligence
Exscientia
Novo Holdings

Pages